C. Halter

发表

Genomewide association study for susceptibility genes contributing to familial Parkinson disease

K. Doheny, E. Pugh, J. Gusella, 2009, Human Genetics.

How treatment of persons with serious mental illness is portrayed in undergraduate psychology textbooks

G. Bond, C. Halter, Rebecca Graaf-Kaser, 1992, Community Mental Health Journal.

Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia

Tatiana Foroud, Nathan Pankratz, T. Foroud, 2006, Movement disorders : official journal of the Movement Disorder Society.

Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants

E. Tolosa, K. Marder, C. Tanner, 2014, Genetics in Medicine.

LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8

T. Foroud, A. Rudolph, N. Pankratz, 2007, Neurology.

The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

Norbert Schuff, Arthur W. Toga, John Seibyl, 2018, Annals of clinical and translational neurology.

Mutations in LRRK2 other than G2019S are rare in a north american–based sample of familial Parkinson's disease

T. Foroud, A. Rudolph, N. Pankratz, 2006, Movement disorders : official journal of the Movement Disorder Society.

Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease

L. Seeberger, K. Marder, D. Jennings, 2003, Neurology.

Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset

T. Foroud, A. Rudolph, N. Pankratz, 2009, Neurology.

Mutations in DJ-1 are rare in familial Parkinson disease

T. Foroud, A. Rudolph, N. Pankratz, 2006, Neuroscience Letters.

Genomewide association study for onset age in Parkinson disease

Tatiana Foroud, Nathan Pankratz, Anita L DeStefano, 2009, BMC Medical Genetics.

Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease

Tatiana Foroud, Nathan Pankratz, Shushant Jain, 2005, The Lancet.

Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families.

J. Jankovic, K. Marder, W. Weiner, 2003, Human molecular genetics.

Evaluation of the role of Nurr1 in a large sample of familial Parkinson's disease

T. Foroud, A. Rudolph, T. Reed, 2004, Movement disorders : official journal of the Movement Disorder Society.

Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations

K. Marder, T. Foroud, A. Rudolph, 2009, Neurology.

Copy Number Variation in Familial Parkinson Disease

Jemma B. Wilk, Anita L. DeStefano, Richard H. Myers, 2011, PloS one.

Significant linkage of Parkinson disease to chromosome 2q36-37.

L. Seeberger, E. Siemers, K. Marder, 2003, American journal of human genetics.

Reliability of reported age at onset for Parkinson's disease

T. Foroud, D. Oakes, C. Halter, 2003, Movement disorders : official journal of the Movement Disorder Society.

Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations.

T. Foroud, A. Rudolph, N. Pankratz, 2002, American journal of human genetics.

Linkage stratification and mutation analysis at the parkin locus identifies mutation positive Parkinson's disease families

L. Seeberger, K. Blindauer, T. Foroud, 2002, Journal of medical genetics.

Variation in GIGYF2 is not associated with Parkinson disease

T. Foroud, A. Rudolph, N. Pankratz, 2009, Neurology.

Alpha‐synuclein and familial Parkinson's disease

T. Foroud, A. Rudolph, N. Pankratz, 2009, Movement disorders : official journal of the Movement Disorder Society.

Clinical correlates of depressive symptoms in familial Parkinson's disease

K. Marder, T. Foroud, A. Rudolph, 2008, Movement disorders : official journal of the Movement Disorder Society.

Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease

T. Foroud, A. Rudolph, D. Simon, 2010, BMC Medical Genetics.

Novel recruitment strategy to enrich for LRRK2 mutation carriers

T. Foroud, L. Wetherill, K. Marek, 2015, Molecular genetics & genomic medicine.

R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation

T. Foroud, A. Rudolph, N. Pankratz, 2007, Movement disorders : official journal of the Movement Disorder Society.

Genes influencing Parkinson disease onset

T. Foroud, A. Rudolph, N. Pankratz, 2004, Neurology.

Genomewide Association Study for Onset Age in Parkinson Disease

J. Gusella, T. Foroud, C. Mariani, 2009 .

Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations

A. Rudolph, C. Halter, M. Pauciulo, 2009, Neurology.

Genomewide linkage study of modifiers of LRRK2‐related Parkinson's disease

J. Gusella, T. Foroud, J. Wilk, 2011, Movement disorders : official journal of the Movement Disorder Society.

' s response to reviews Title : Genomewide Association Study for Onset Age in Parkinson Disease

J. Gusella, T. Foroud, C. Mariani, 2009 .

Bmc Medical Genetics Genomewide Association Study for Onset Age in Parkinson Disease

J. Gusella, T. Foroud, C. Mariani, 2022 .